Dr Beatrice Seddon, Consultant Clinical Oncologist

Dr Beatrice Seddon

Consultant Clinical Oncologist

Book online
|

Dr Beatrice Seddon MBBS MRCP FRCR PhD

Consultant Clinical Oncologist

MBBS MRCP FRCR PhD

Dr Beatrice Seddon

Consultant Clinical Oncologist MBBS MRCP FRCR PhD

Book online
|
MBBS MRCP FRCR PhD

Areas of expertise

  • Soft tissue disorders
  • Sarcoma
  • Gastrointestinal stromal tumours
  • Chemotherapy
  • Radiotherapy

Recommendations for Dr Seddon

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byDr George Webster, Gastroenterologist and Hepatologist

    Nationally renowned expert in sarcoma. Excellent specialist opinion.

  • byDr George Webster, Gastroenterologist and Hepatologist

    Nationally renowned expert in sarcoma. Excellent specialist opinion.

  • Address

    • HCA UK at University College Hospital

      Grafton Way Building, 1 Grafton Way, London, WC1E 6AG

    • LOC - Leaders in Oncology Care

      95-97 Harley Street, London, W1G 6AF

    About Dr Beatrice Seddon

    GMC number: 3453405

    Year qualified: 1990

    Place of primary qualification: University of London

    Areas of expertise

    • Soft tissue and bone sarcomas
    • Gastrointesintal stromal tumours
    • Gynaecological sarcomas

    Professional memberships

    European Organisation for Research and Treatment of Cancer
    National Cancer Research Institute
    General Medical Council

    Articles by Dr Beatrice Seddon

    Title: whole genome sequencing of 1,111 sarcoma probands reveals pot-1 as a sarcoma predisposition gene presentation type: oral current category: basic science|genomics authors (first name, last name)

    The hypoxia marker caix is prognostic in the uk phase iii vortex-biobank cohort: an important resource for translational research in soft tissue sarcoma

    Cediranib in patients with alveolar soft-part sarcoma (casps): a double-blind, placebo-controlled, randomised, phase 2 trial

    Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood

    Po-0742: target delineation conformity in extremity sts within the uk phase ii multi-centre imris trial

    Oc-0449: a novel and objective plan evaluation for limb sarcomas imrt in the imris phase ii trial

    Seeking international consensus on approaches to primary tumour treatment in ewing sarcoma

    Other specialists recommended by Dr Seddon